MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,401,943 | -59.8% | 5,040,900 | +4.2% | 0.01% | -62.9% |
| Q2 2023 | $15,922,004 | +41086.8% | 4,839,515 | +73259.3% | 0.04% | – |
| Q4 2022 | $38,658 | -91.0% | 6,597 | -89.6% | 0.00% | -100.0% |
| Q3 2022 | $430,000 | +68.6% | 63,527 | +15.0% | 0.00% | 0.0% |
| Q2 2022 | $255,000 | +123.7% | 55,249 | +93.7% | 0.00% | – |
| Q1 2022 | $114,000 | +25.3% | 28,525 | +95.0% | 0.00% | – |
| Q4 2021 | $91,000 | -71.4% | 14,630 | -25.5% | 0.00% | -100.0% |
| Q1 2021 | $318,000 | -91.5% | 19,636 | -90.3% | 0.00% | -92.9% |
| Q3 2020 | $3,760,000 | +941.6% | 201,958 | +459.6% | 0.03% | +1300.0% |
| Q3 2018 | $361,000 | -75.5% | 36,090 | -56.3% | 0.00% | -71.4% |
| Q2 2018 | $1,475,000 | – | 82,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 1,191,271 | $6,980,848 | 6.79% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $50,769 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 950,000 | $5,567,000 | 3.43% |
| Sarissa Capital Management LP | 3,997,010 | $23,422,479 | 2.79% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $5,299,010 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,140,182 | $6,681,467 | 1.91% |
| Orbimed Advisors | 9,011,437 | $52,807,021 | 1.01% |
| Opaleye Management Inc. | 460,000 | $2,695,600 | 0.94% |
| Artal Group S.A. | 2,200,000 | $12,892 | 0.72% |
| DAFNA Capital Management LLC | 413,463 | $2,422,893 | 0.68% |